Highlights

  • Alpha HPA Ltd successfully completed an AUD 225m fully underwritten capital raising to fund Stage 2 of the HPA First Project
  • The capital raise was structured as a two-tranche placement, comprising AUD 105m unconditional and AUD 120m subject to shareholder approval
  • Post-raising, Alpha will have access to up to AUD 704m in available funding lines and ~AUD 497m in government-backed facilities and grants
  • Recent quarterly results highlighted record semiconductor shipments and binding CY2026 supply contracts, reinforcing demand momentum

Alpha HPA Ltd (ASX:A4N) has successfully completed a fully underwritten AUD 225 million capital raising, reinforcing its balance sheet and accelerating the construction and commercialisation of Stage 2 of its HPA First Project.  Despite this favourable update, the stock has declined 13.61% to AUD 0.73 on 30 January 2026.

The equity raising was completed via a two-tranche placement at AUD 0.75 per share, involving the issuance of approximately 300 million new shares:

  • Tranche 1: AUD 105m (unconditional, using existing placement capacity)
  • Tranche 2: AUD 120m (subject to shareholder approval at a General Meeting expected around 11 March 2026)

The placement was fully underwritten and attracted favourable demand from existing and new institutional investors. Notably, the National Reconstruction Fund Corporation (NRFC) invested AUD 75m, emerging as a substantial shareholder with a ~6.9% pro-forma stake. AustralianSuper and Orica Limited also participated, signalling continued confidence from cornerstone investors.

Capital Deployment and Funding Access Support Expansion

Alongside the placement, Alpha will offer eligible shareholders a non-underwritten Share Purchase Plan (SPP), allowing applications of up to AUD 30,000 per investor. Shares will be issued at the lower of AUD 0.75 or a 2% discount to the 5-day VWAP, providing retail investors an opportunity to participate on similar terms.

Proceeds from the capital raising combined with ~AUD 39m in existing cash will be directed towards Construction and commercialisation of Stage 2 of the HPA First Project, Unlocking additional capacity from Stage 1 and general corporate purposes

Following the placement, Alpha will have access to up to AUD 704m in available funding lines, supplemented by approximately AUD 497m in government-backed facilities, grants, and critical minerals funding, significantly de-risking project execution.

What’s Next for the Investors?

While the market’s immediate focus is on funding, Alpha’s recent quarterly update released on 29 January 2026 highlights strengthening fundamentals. The company reported record semiconductor sector shipments, binding CY2026 supply contracts with South Korean customers, and contract negotiations that exceed current Stage 1 capacity. Stage 2 is expected to become the world’s largest single-site facility for high purity aluminium materials, positioning Alpha deeper into global semiconductor supply chains.

The AUD 225m capital raising marks a strategic inflection point for Alpha HPA. With favourable institutional backing, government support, and rising demand across high-growth end markets, the company is now well-funded to execute its Stage 2 expansion. While recent share price weakness reflects near-term dilution and market volatility, the transaction materially strengthens Alpha’s long-term growth and commercialisation pathway. The share has declined and 13.61% on 30 January 2026 and is also down by 16.09% over the one-year period.